<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lin J</submitter><funding>Natural Sciences and Engineering Research Council of Canada</funding><funding>China Scholarship Council</funding><funding>Natural Sciences and Engineering Research Council of Canada (NSERC)</funding><funding>York University’s Dean’s Undergraduate Research Award</funding><funding>USDA National Institute of Food and Agriculture</funding><pagination>545</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9921300</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(3)</volume><pubmed_abstract>Glyceollins, isoflavonoid-derived antimicrobial metabolites, are the major phytoalexins in soybean (&lt;i>Glycine max&lt;/i>). They play essential roles in providing resistance to the soil-borne pathogen &lt;i>Phytophthora sojae&lt;/i> and have unconventional anticancer and neuroprotective activities that render them desirable for pharmaceutical development. Our previous studies revealed that the transcription factors GmMYB29A2 and GmNAC42-1 have essential roles in activating glyceollin biosynthesis, yet each cannot activate the transcription of all biosynthesis genes in the absence of a pathogen elicitor treatment. Here, we report that co-overexpressing both transcription factors is also insufficient to activate glyceollin biosynthesis. To understand this insufficiency, we compared the transcriptome </pubmed_abstract><journal>Plants (Basel, Switzerland)</journal><pubmed_title>RNA-Seq Dissects Incomplete Activation of Phytoalexin Biosynthesis by the Soybean Transcription Factors GmMYB29A2 and GmNAC42-1.</pubmed_title><pmcid>PMC9921300</pmcid><funding_grant_id>202107980003</funding_grant_id><funding_grant_id>1010200</funding_grant_id><funding_grant_id>RGPIN-2020-06111</funding_grant_id><pubmed_authors>Kovinich N</pubmed_authors><pubmed_authors>Jahan MA</pubmed_authors><pubmed_authors>Monsalvo I</pubmed_authors><pubmed_authors>Martirosyan I</pubmed_authors><pubmed_authors>Lin J</pubmed_authors><pubmed_authors>Ly M</pubmed_authors><pubmed_authors>Wi D</pubmed_authors></additional><is_claimable>false</is_claimable><name>RNA-Seq Dissects Incomplete Activation of Phytoalexin Biosynthesis by the Soybean Transcription Factors GmMYB29A2 and GmNAC42-1.</name><description>Glyceollins, isoflavonoid-derived antimicrobial metabolites, are the major phytoalexins in soybean (&lt;i>Glycine max&lt;/i>). They play essential roles in providing resistance to the soil-borne pathogen &lt;i>Phytophthora sojae&lt;/i> and have unconventional anticancer and neuroprotective activities that render them desirable for pharmaceutical development. Our previous studies revealed that the transcription factors GmMYB29A2 and GmNAC42-1 have essential roles in activating glyceollin biosynthesis, yet each cannot activate the transcription of all biosynthesis genes in the absence of a pathogen elicitor treatment. Here, we report that co-overexpressing both transcription factors is also insufficient to activate glyceollin biosynthesis. To understand this insufficiency, we compared the transcriptome </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2026-05-13T14:33:25.784Z</modification><creation>2024-11-09T20:45:36.008Z</creation></dates><accession>S-EPMC9921300</accession><cross_references><pubmed>36771629</pubmed><doi>10.3390/plants12030545</doi></cross_references></HashMap>